Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 30Breast 28Thoracic 21Genitourinary 20Sarcoma 12Dermatologic 12Head & Neck 7Other solid neoplasm 5Gynecologic 4CNS 3Tumor-Agnostic 2Lymphoid 2Other hematologic neoplasm 1NET 1Endocrine 1

Conditions

Neoplasm Metastasis 2

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cryosurgery × Tumor-Agnostic × Clear all
NCT04150939 2026-02-17

Cryoablation for the Treatment of Metastatic Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
15 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04713371 2024-05-09

A Phase 2 Trial for Patients With Metastatic Solid Cancer

Rampart Health, L.L.C.

Phase 2 Unknown
32 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡